A novel monoclonal antibody specific for cocaine. 2013

Hiroshi Nakayama, and Noriko Kenjyou, and Nobuyuki Shigetoh
Bioscience Technology Development Office, R&D Division, Panasonic Co., Soraku-gun, Japan. nakayama.healther@jp.panasonic.com

Detection systems for the illegal drug cocaine need to have a high sensitivity and specificity for cocaine and to be relatively easy to use. In the current study, a monoclonal antibody (MAb) with a high specificity for cocaine was produced. Enzyme-linked immunosorbent assay and fluorescence quenching immunoassay were used to screen the hybridomas. The MAb S27Y (IgG1) was shown to be sensitive and specific for cocaine and quenched fluorescence. Thus, S27Y has the potential to be used in screening assays for the rapid and sensitive detection of cocaine.

UI MeSH Term Description Entries
D008805 Mice, Inbred A An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. Mouse, Inbred A,Inbred A Mice,Inbred A Mouse
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D005453 Fluorescence The property of emitting radiation while being irradiated. The radiation emitted is usually of longer wavelength than that incident or absorbed, e.g., a substance can be irradiated with invisible radiation and emit visible light. X-ray fluorescence is used in diagnosis.
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody

Related Publications

Hiroshi Nakayama, and Noriko Kenjyou, and Nobuyuki Shigetoh
November 2000, The Histochemical journal,
Hiroshi Nakayama, and Noriko Kenjyou, and Nobuyuki Shigetoh
January 1997, Folia biologica,
Hiroshi Nakayama, and Noriko Kenjyou, and Nobuyuki Shigetoh
May 1996, Japanese journal of cancer research : Gann,
Hiroshi Nakayama, and Noriko Kenjyou, and Nobuyuki Shigetoh
April 2005, Immunology letters,
Hiroshi Nakayama, and Noriko Kenjyou, and Nobuyuki Shigetoh
June 2009, Hybridoma (2005),
Hiroshi Nakayama, and Noriko Kenjyou, and Nobuyuki Shigetoh
October 2009, Hybridoma (2005),
Hiroshi Nakayama, and Noriko Kenjyou, and Nobuyuki Shigetoh
December 2014, Cell death & disease,
Hiroshi Nakayama, and Noriko Kenjyou, and Nobuyuki Shigetoh
December 2002, Journal of medicinal chemistry,
Hiroshi Nakayama, and Noriko Kenjyou, and Nobuyuki Shigetoh
February 2004, Current medicinal chemistry,
Hiroshi Nakayama, and Noriko Kenjyou, and Nobuyuki Shigetoh
January 1993, Haemostasis,
Copied contents to your clipboard!